Summary
Merck & Co., Inc. (MRK) filed a Form 8-K on May 20, 2013, to report the closing of a significant underwritten public offering of debt securities. The company successfully raised a total of $6.4 billion through the issuance of various notes with different maturities and interest rate structures. This debt issuance includes $1 billion in 0.700% Notes due 2016, $500 million in Floating Rate Notes due 2016, $1 billion in 1.300% Notes due 2018, $1 billion in Floating Rate Notes due 2018, $1.75 billion in 2.800% Notes due 2023, and $1.25 billion in 4.150% Notes due 2043.
Key Highlights
- 1Merck closed a substantial public offering of debt, raising a total of $6.4 billion.
- 2The offering comprised six series of notes with maturities ranging from 2016 to 2043.
- 3Included in the offering were both fixed-rate notes and floating-rate notes.
- 4The fixed-rate notes offered had coupon rates ranging from 0.700% to 4.150%.
- 5The debt issuance was conducted under the company's effective Registration Statement on Form S-3 (Registration No. 333-185248).
- 6The company has provided detailed exhibits, including officers' certificates and legal opinions, related to the issuance of each series of notes.
Frequently Asked Questions
Merck raised a total of $6.4 billion through the underwritten public offering of debt securities.
Merck issued a combination of fixed-rate notes with varying interest rates and maturities (2016, 2018, 2023, and 2043) and floating-rate notes due in 2016 and 2018.
While this specific 8-K filing does not detail the exact use of proceeds, debt issuances are typically used for general corporate purposes, which can include refinancing existing debt, funding operations, acquisitions, research and development, or capital expenditures.
More detailed information can be found in the exhibits attached to this Form 8-K, specifically the officers' certificates for each series of notes and the legal opinions. The notes were issued under an indenture dated January 6, 2010, which was previously filed.